Lars Fruergaard Jørgensen

Tariff wars: Novo Nordisk CEO echoes pharma industry caution on possible drug shortages and price increases

In the midst of tariffs threatened by the US and counter-tariffs by other countries, Danish healthcare company Novo Nordisk’s top…

8 hours ago